Oddbjørn Straume

7.0k total citations · 2 hit papers
69 papers, 4.6k citations indexed

About

Oddbjørn Straume is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Oddbjørn Straume has authored 69 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 40 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Oddbjørn Straume's work include Angiogenesis and VEGF in Cancer (21 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cutaneous Melanoma Detection and Management (16 papers). Oddbjørn Straume is often cited by papers focused on Angiogenesis and VEGF in Cancer (21 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cutaneous Melanoma Detection and Management (16 papers). Oddbjørn Straume collaborates with scholars based in Norway, United States and Sweden. Oddbjørn Straume's co-authors include Lars A. Akslen, Hanna Dillekås, Michael S. Rogers, Ingeborg Bachmann, Helga B. Salvesen, Ingunn M. Stefansson, George N. Naumov, Judah Folkman, Ole J. Halvorsen and Svein A. Haukaas and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Oddbjørn Straume

69 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

2005 694 citations Ingeborg Bachmann, Ingunn M. Stefansson et al. profile →
Are 90% of deaths from cancer caused by metastases?

2019 606 citations Hanna Dillekås, Michael S. Rogers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oddbjørn Straume Norway	31	2.8k	2.4k	1.3k	694	495	69	4.6k
Cristina Nadal Spain	17	2.2k 0.8×	2.3k 1.0×	1.3k 1.0×	726 1.0×	475 1.0×	42	4.3k
Baocun Sun China	39	2.8k 1.0×	1.7k 0.7×	1.5k 1.2×	783 1.1×	478 1.0×	145	4.6k
Laura K. Shawver United States	26	3.4k 1.2×	2.0k 0.8×	1.2k 0.9×	562 0.8×	363 0.7×	47	5.1k
Dingcheng Gao United States	26	2.8k 1.0×	2.5k 1.1×	1.8k 1.4×	853 1.2×	936 1.9×	36	5.1k
Xiulan Zhao China	44	3.8k 1.4×	2.0k 0.9×	2.3k 1.8×	718 1.0×	539 1.1×	135	5.5k
Alana L. Welm United States	41	4.0k 1.4×	2.4k 1.0×	1.8k 1.4×	745 1.1×	799 1.6×	97	6.5k
Oriol Casanovas Spain	32	3.8k 1.4×	2.3k 1.0×	2.1k 1.6×	896 1.3×	591 1.2×	70	6.2k
Thomas Karn Germany	37	2.3k 0.8×	2.2k 0.9×	1.7k 1.3×	691 1.0×	794 1.6×	141	4.9k
Adrian M. Jubb United Kingdom	32	2.5k 0.9×	1.6k 0.7×	1.0k 0.8×	630 0.9×	351 0.7×	50	4.0k
Sandra S. McAllister United States	24	2.3k 0.8×	2.8k 1.2×	1.2k 0.9×	1.1k 1.5×	1.1k 2.3×	46	5.1k

Countries citing papers authored by Oddbjørn Straume

Since Specialization

Citations

This map shows the geographic impact of Oddbjørn Straume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oddbjørn Straume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oddbjørn Straume more than expected).

Fields of papers citing papers by Oddbjørn Straume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oddbjørn Straume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oddbjørn Straume. The network helps show where Oddbjørn Straume may publish in the future.

Co-authorship network of co-authors of Oddbjørn Straume

This figure shows the co-authorship network connecting the top 25 collaborators of Oddbjørn Straume. A scholar is included among the top collaborators of Oddbjørn Straume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oddbjørn Straume. Oddbjørn Straume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krüger, Kristi, Laxmi Silwal‐Pandit, Elisabeth Wik, et al.. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Scientific Reports. 11(1). 3388–3388. 16 indexed citations

Straume, Oddbjørn, et al.. (2020). HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?. PharmacoEconomics - Open. 4(3). 529–539. 2 indexed citations

Beisland, Christian, et al.. (2019). Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. Cancer Treatment and Research Communications. 19. 100127–100127. 15 indexed citations

Dillekås, Hanna, et al.. (2016). The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Research and Treatment. 158(1). 169–178. 53 indexed citations

Tzoulis, Charalampos, Thomas Schwarzlmüller, Ivar Gjerde, et al.. (2015). Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. BMC Research Notes. 8(1). 171–171. 24 indexed citations

Rogers, Michael S., Katherine B. Novak, David Zurakowski, et al.. (2014). Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors. Molecular Cancer Research. 12(5). 754–764. 11 indexed citations

Dillekås, Hanna, et al.. (2014). Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases. Breast Cancer Research and Treatment. 146(3). 627–636. 18 indexed citations

Ladstein, Rita G, Ingeborg Bachmann, Oddbjørn Straume, & Lars A. Akslen. (2013). Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. Modern Pathology. 27(3). 396–401. 12 indexed citations

Akslen, Lars A., Oddbjørn Straume, Stephanie Geisler, et al.. (2011). Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. British Journal of Cancer. 105(1). 9–12. 13 indexed citations

10.

Ladstein, Rita G, Ingeborg Bachmann, Oddbjørn Straume, & Lars A. Akslen. (2010). Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. BMC Cancer. 10(1). 140–140. 101 indexed citations

11.

Akslen, Lars A., Hanne Puntervoll, Ingeborg Bachmann, et al.. (2008). Mutation analysis of the EGFR–NRAS–BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma Research. 18(1). 29–35. 65 indexed citations

12.

Stuhr, Linda, Vegard V. Iversen, Oddbjørn Straume, Bjørn O. Mæhle, & Rolf K. Reed. (2004). Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. Cancer Letters. 210(1). 35–40. 45 indexed citations

13.

Straume, Oddbjørn & Lars A. Akslen. (2003). Increased Expression of VEGF-Receptors (FLT-1, KDR, NRP-1) and Thrombospondin-1 is Associated with Glomeruloid Microvascular Proliferation, an Aggressive Angiogenic Phenotype, in Malignant Melanoma. Angiogenesis. 6(4). 295–301. 45 indexed citations

14.

Straume, Oddbjørn, et al.. (2003). Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer. British Journal of Cancer. 89(6). 1031–1034. 42 indexed citations

15.

Straume, Oddbjørn, Johanna Smeds, Rajiv Kumar, Kari Hemminki, & Lars A. Akslen. (2002). Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase. American Journal Of Pathology. 161(1). 229–237. 78 indexed citations

16.

Straume, Oddbjørn & Lars A. Akslen. (2001). Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas. American Journal Of Pathology. 159(1). 223–235. 128 indexed citations

17.

Akslen, Lars A., et al.. (1998). Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. International Journal of Cancer. 79(1). 91–95. 35 indexed citations

18.

Straume, Oddbjørn & Lars A. Akslen. (1997). Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. International Journal of Cancer. 74(5). 535–539. 97 indexed citations

19.

Straume, Oddbjørn & Lars A. Akslen. (1996). Independent prognostic importance of vascular invasion in nodular melanomas. Cancer. 78(6). 1211–1219. 3 indexed citations

20.

Straume, Oddbjørn & Lars A. Akslen. (1996). Independent prognostic importance of vascular invasion in nodular melanomas. Cancer. 78(6). 1211–1219. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact